Inventor · Shanghai, CN

Zonghai LI

15Patents
3h-index
19Co-inventors
53Inventor score

Filing activity: Sep 22, 2009 → Mar 8, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8506963B2 Anti-EFGRv3 monoclonal antibody Chemistry; Metallurgy 14 Active
US11111295B2 Antibody for anti-claudin 18A2 and use thereof Chemistry; Metallurgy 4 Active
US9969799B2 Anti-human proBDNF monoclonal antibody, and uses thereof in pains Chemistry; Metallurgy 4 Active
US10023639B2 Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and T cell antigen Chemistry; Metallurgy 3 Active
US10604740B2 Nucleic acids encoding chimeric antigen receptor proteins which bind epidermal growth factor receptor and T lymphocyte expressing the protein Chemistry; Metallurgy 3 Active
US10731127B2 Chimeric antigen receptors targeting GPC3 and uses thereof Chemistry; Metallurgy 3 Active
US11447570B2 Binding unit targeting fibroblast activation protein α and application thereof Chemistry; Metallurgy 2 Active
US8703917B2 Epidermal growth factor receptor variants and pharmaceutical compositions thereof Physics 2 Active
US8796421B2 Human epidermal growth factor receptor variant lacking an exon Chemistry; Metallurgy 1 Active
US12186343B2 Method and composition for treating tumors Chemistry; Metallurgy 0 Active
US11419895B2 Compositions and methods of cellular immunotherapy Chemistry; Metallurgy 0 Active
US11596653B2 Compositions and methods of cellular immunotherapy Chemistry; Metallurgy 0 Active
US11299525B2 Chimeric antigen receptor-modified immune effector cell carrying PD-L1 blocking agent Chemistry; Metallurgy 0 Active
US11427633B2 Anti-CD19 humanized antibody and immune effector cell targeting cd 19 Chemistry; Metallurgy 0 Active
US12178786B2 Combination of cellular immunotherapy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.